Naveen Pemmaraju: Nice to see so many colleagues form around the world at MPNCoandD Congress

Naveen Pemmaraju shared a post on LinkedIn:

“ Nice to see so many colleagues form around the world  in Paris for International Academy for Clinical Hematology (IACH) MPNCo&D Congress at intersection of MDS, MPN, and SCT.

Very important discussions.”

Source: Naveen Pemmaraju/LinkedIn

Naveen Pemmaraju is a Professor and Director of BPDCN Program at the Department of Leukemia at the University of Texas MD Anderson Cancer Center (MDACC) and Executive Director of MDACC Network. He is also the Leukemia Hematology/Oncology Course Director. His research work has been focused on improving outcomes and developing novel therapies for patients with rare, and ultra-rare, myeloid malignancies; including adolescents, young adults, and older adult patients with Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN), MPN and AML.